Bitte beachten Sie, dass die von Ihnen aufgerufene Seite nicht in Ihrer Standardsprache vorliegt. Sie nutzen unsere Plattform nun in einer anderen Sprache.
In the United States, the average value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health and pharmaceuticals sector as of 2023 was a multiple of approximately 13.7x. Companies operating in the healthcare (information & technology) industries saw the highest valuation multiple with EV/EBITDA ratio of 19.3x in 2023, down from 25.6x in 2022.
Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2023, by industry
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Hispanic health in the U.S.
Overview
4
- Basic Statistic Birth rate of Hispanics in the U.S. 1990-2021
- Premium Statistic Leading causes of death among Hispanics in the U.S. 2020 and 2021
- Basic Statistic Prevalence of obesity among Latinos in the U.S. by state 2022
- Premium Statistic Percentage of current asthma among Hispanics in the United States 2019-2021
Cancer
5
- Basic Statistic Probability of developing cancer among U.S. Hispanics in 2016-2018, by cancer type
- Basic Statistic Number of new cancer cases among U.S. Hispanic males in 2021, by cancer type
- Basic Statistic Number of new cancer cases among U.S. Hispanic females in 2021, by cancer type
- Premium Statistic Number of cancer deaths among U.S. Hispanic males in 2021, by cancer type
- Premium Statistic Number of cancer deaths among U.S. Hispanic females in 2021, by cancer type
Sexual health
4
- Basic Statistic Rate of HIV diagnoses among Hispanics in the U.S. 2021, by age
- Premium Statistic Cases of chlamydia among Hispanics in the United States 2022, by age group and gender
- Basic Statistic Cases of gonorrhea among Hispanics in the United States 2022, by age group and gender
- Basic Statistic Cases of syphilis among Hispanics in the United States 2022, by age group and gender
Mental health
6
- Basic Statistic Any mental illness in the past year among U.S. Hispanic adults 2008-2022
- Basic Statistic Major depressive episode in the past year among U.S. Hispanic adults 2005-2020
- Premium Statistic Share of U.S. Hispanics with a major depressive episode from 2017-2020, by age
- Premium Statistic Suicidal thoughts among U.S. Hispanic adults 2008-2022
- Basic Statistic Share of U.S. Hispanic adults receiving mental health treatment 2002-2022
- Premium Statistic Share of U.S. Hispanics with mental illness who didn't receive treatment as of 2021
Substance use
8
- Premium Statistic U.S. drug overdose age-adjusted death rate among Hispanics 1999-2022
- Basic Statistic Share of Hispanics in the U.S. who used illicit drugs in 2021, by drug type
- Premium Statistic Past-month alcohol use among U.S. persons aged 12 or older by race/ethnicity 2022
- Basic Statistic Alcohol use among Hispanics in the U.S. by age 2017-2020
- Basic Statistic Share of U.S. Hispanics who had used marijuana in the past month 2017-2020, by age
- Premium Statistic Share of Hispanics who misused opioids in the U.S. in 2017 and 2020, by age
- Basic Statistic Binge drinking and tobacco use among Hispanics in the U.S. 2021, by mental health
- Basic Statistic Past year substance use and mental illness among Hispanics in the U.S. 2021
Health insurance
3
Further related statistics
10
- Financial advisors ranked by M&A transactions in the UK 2022, by deal value
- Hugo Boss - EBITDA 2005-2023
- Net earnings of UnitedHealth Group 2007-2023
- Leading financial advisors to M&A deals in the UK 2022, by deal volume
- Overweight prevalence in England 2000-2021, by gender
- Medicaid long-term care services expenditures by type of service 1990-21
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
- Deaths by prostate cancer in the U.S. 1950-2019
Further Content: You might find this interesting as well
Statistics
- Financial advisors ranked by M&A transactions in the UK 2022, by deal value
- Hugo Boss - EBITDA 2005-2023
- Net earnings of UnitedHealth Group 2007-2023
- Leading financial advisors to M&A deals in the UK 2022, by deal volume
- Overweight prevalence in England 2000-2021, by gender
- Medicaid long-term care services expenditures by type of service 1990-21
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
- Deaths by prostate cancer in the U.S. 1950-2019
Topics
Health careLeonard N. Stern School of Business. (January 5, 2023). Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2023, by industry [Graph]. In Statista. Retrieved June 11, 2024, from https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/
Leonard N. Stern School of Business. "Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2023, by industry." Chart. January 5, 2023. Statista. Accessed June 11, 2024. https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/
Leonard N. Stern School of Business. (2023). Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2023, by industry. Statista. Statista Inc.. Accessed: June 11, 2024. https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/
Leonard N. Stern School of Business. "Average Ev/Ebitda Multiples in The Health and Pharmaceuticals Sector in The United States from 2019 to 2023, by Industry." Statista, Statista Inc., 5 Jan 2023, https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/
Leonard N. Stern School of Business, Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2023, by industry Statista, https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/ (last visited June 11, 2024)
Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2023, by industry [Graph], Leonard N. Stern School of Business, January 5, 2023. [Online]. Available: https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/